chr6-129391535-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000426.4(LAMA2):c.5116C>T(p.Arg1706*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,613,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R1706R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000426.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | ENST00000421865.3 | c.5116C>T | p.Arg1706* | stop_gained | Exon 36 of 65 | 5 | NM_000426.4 | ENSP00000400365.2 | ||
| LAMA2 | ENST00000618192.5 | c.5380C>T | p.Arg1794* | stop_gained | Exon 37 of 66 | 5 | ENSP00000480802.2 | |||
| LAMA2 | ENST00000617695.5 | c.5116C>T | p.Arg1706* | stop_gained | Exon 36 of 64 | 5 | ENSP00000481744.2 | |||
| LAMA2 | ENST00000687590.1 | n.1536C>T | non_coding_transcript_exon_variant | Exon 4 of 5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152024Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000240 AC: 6AN: 250502 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461616Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727118 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152024Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74232 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Merosin deficient congenital muscular dystrophy Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
Muscular dystrophy, limb-girdle, autosomal recessive 23 Pathogenic:2
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.002%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000287913 /PMID: 9674786). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
The stop gained p.R1706* in LAMA2 (NM_000426.4) has been reported previously in affected patients (Geranmayeh F et al, Reddy HM et al). This has been submitted to ClinVar as Pathogenic. The p.R1706* variant is observed in 2/34,524 (0.0058%) alleles from individuals of Latino background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been reviously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. -
LAMA2-related muscular dystrophy Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg1706*) in the LAMA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA2 are known to be pathogenic (PMID: 18700894, 32904964). This variant is present in population databases (rs758775001, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with muscular dystrophy (PMID: 9674786, 20207543, 27708273). ClinVar contains an entry for this variant (Variation ID: 287913). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Merosin deficient congenital muscular dystrophy;C4748327:Muscular dystrophy, limb-girdle, autosomal recessive 23 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at